You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. A mechanism-based computational tool to optimize pulmonary drug delivery

    SBC: 3DT HOLDINGS, LLC            Topic: NHLBI

    DESCRIPTION (provided by applicant): Coronary artery disease (CAD) is a national and worldwide epidemic that places the largest clinical and economic burden on the healthcare system of any disease condition. Patients with stable and acute coronary conditions are often treated with percutaneous coronary intervention (PCI), including stenting. Up to 85% of all coronary stents are under-deployed lead ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  2. A Miniature Non-Contact Rail Temperature Sensor

    SBC: En'urga Inc.            Topic: 081FR2

    The Phase I SBIR project will evaluate the feasibility of utilizing a low cost sensor to obtain rail temperatures from a moving train. The two innovative parts of the proposed sensor are (1) a rugged four wavelenght high frequency sensor that accurately measures the natural radiation emitted by the rails, and (2) an advanced algorithm that provides a emissivity compensated temperature from these ...

    SBIR Phase I 2009 Department of Transportation
  3. A Novel Device Design for Sperm Cryopreservation

    SBC: GENERAL BIOTECHNOLOGY, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Genetically engineered mouse (GEM) and rat (GER) lines are excellent animal models for many important human diseases (Cox, 2003; Green and Hudson, 2005). However, maintenance of these lines by standard breeding techniques is producing unsustainable pressure on facilities and budgets. Consequently, there is a critical need to develop reliable and cost-effective ...

    SBIR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  4. CLINICAL WORLDS: ENHANCING SUBSTANCE ABUSE PROVIDER TRAINING THROUGH EMERGING TEC

    SBC: ACADEMIC EDGE, INC.            Topic: N/A

    Location 108 E. 14th Street BLOOMINGTON, IN 47408 United States N43DA0900006 $100 000.00 2 009 CLINICAL WORLDS: ENHANCING SUBSTANCE ABUSE PROVIDER TRAINING THROUGH EMERGING TEC Department of Health and Human Services National Institutes of Health SBIR PHS ...

    SBIR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  5. Creating a Global Infrastructure for Virtual Aids to Navigation (V-ATON)

    SBC: WisdomTools Enterprises Inc            Topic: N/A

    Not Available Today's dense and rapidly evolving threat environments have increased the requirements that are being placed on tools necessary for characterizing urban electromagnetic (EM) environments. Although effective tools for urban EM environment characterization exist for simple 2-D models, the more challenging problem of characterizing the EM environment of a large densely populated region ...

    SBIR Phase I 1999 Department of Transportation
  6. Development of a niobuim oxide as a potential coating for dental and orthopedic i

    SBC: Indiana Nanotech, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): The worldwide market for implant-based dental products is forecasted to approach 3.5 billion by 2010, and although only 9% of the global dental market is allocated to dental implants, it is the fastest growing segment at a rate of 15% per year. These projections could imply that although significant improvements in overall oral health are observed globally, t ...

    SBIR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  7. Dose Imaging Detectors for Radiotherapy Based on Gas Electron Multipliers

    SBC: PARTTEC, LTD.            Topic: N/A

    DESCRIPTION (provided by applicant): In this SBIR project, PartTec will develop a detector that can support the high precision requirements of Intensity Modulated Proton Therapy, the next-generation Proton Therapy. There are no detectors currently available that meet the design goals of this project, in particular high spatial and timing resolution. While efforts have been started in this area ...

    SBIR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  8. Elastic biodegradable ureteral stent

    SBC: AKINA, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The objective of this Phase I study is to develop elastic, biodegradable ureteral stents that will degrade in the body within 2 weeks after a procedure. Current ureteral stents are made of non-degradable polymers and, unless they are permanent, have to be removed by second procedure, which requires further intervention on the patients. Biodegradable ureteral st ...

    SBIR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  9. Identification and Validation of Targets of Phenotypic High Throughput Screening

    SBC: Prosolia, Inc.            Topic: NIGMS

    DESCRIPTION: Development of an Intelligent Sample Introduction System for Mass Spectrometry There is a pressing need for new technologies that enable rapid measurements without significant compromise to the analytical data. Herein, we propose to develop arobust mass spectrometry (MS) based surface sampling device that enables direct analysis of a variety of materials including biological tissue a ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  10. Intravital Fiber-Optic Flow Cytometer

    SBC: IVDIAGNOSTICS, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): The decision to administer chemotherapy following tumor resection usually depends on an oncologist's assessment of the presence of residual disease. While computed tomography, magnetic resonance imaging, or tissue/sentinel lymph node biopsy analysis can detect some level of residual disease (up to a resolution of ~2 mm or ~190,000 cells), the presence of circul ...

    SBIR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government